Head-To-Head Review: Anteris Technologies Global (AVR) & Its Peers

Anteris Technologies Global (NASDAQ:AVR) is one of 142 publicly-traded companies in the “MED INSTRUMENTS” industry, but how does it weigh in compared to its rivals? We will compare Anteris Technologies Global to similar companies based on the strength of its analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends.

Institutional and Insider Ownership

54.1% of shares of all “MED INSTRUMENTS” companies are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by insiders. Comparatively, 14.1% of shares of all “MED INSTRUMENTS” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Anteris Technologies Global and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-3,944.93%	-252.71%	-169.61%
Anteris Technologies Global Competitors	-482.31%	-113.49%	-21.33%

Valuation & Earnings

This table compares Anteris Technologies Global and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Anteris Technologies Global	$2.70 million	-$76.29 million	-2.12
Anteris Technologies Global Competitors	$1.75 billion	$196.07 million	5.23

Anteris Technologies Global’s rivals have higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Anteris Technologies Global and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	0	4	0	2.60
Anteris Technologies Global Competitors	1229	3827	7160	271	2.52

Anteris Technologies Global presently has a consensus target price of $16.50, indicating a potential upside of 329.69%. As a group, “MED INSTRUMENTS” companies have a potential upside of 9.51%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, equities analysts plainly believe Anteris Technologies Global is more favorable than its rivals.

Summary

Anteris Technologies Global rivals beat Anteris Technologies Global on 9 of the 12 factors compared.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.